Q2 2019 Holdings
Filed 2019-08-13 | 15 holdings | $392.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $154.2K | 6,953,416 | 39.3% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $74.6K | 5,103,455 | 19.0% |
| Morphic Holding | Common Stock | 61775R105 | $58.9K | 2,969,582 | 15.0% |
| Translate Bio | Common Stock | 89374L104 | $30.8K | 2,437,603 | 7.9% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $15.7K | 1,371,494 | 4.0% |
| ObsEva | Common Stock | H5861P103 | $11.3K | 999,364 | 2.9% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $10.4K | 2,600,410 | 2.6% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $9.5K | 1,263,408 | 2.4% |
| Prevail Therapeutics | Common Stock | 74140Y101 | $8.8K | 668,908 | 2.3% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $5.9K | 130,646 | 1.5% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $3.5K | 754,457 | 0.9% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $2.7K | 1,084,848 | 0.7% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.6K | 529,965 | 0.7% |
| Cidara Therapeutics | Common Stock | 171757107 | $2.5K | 1,508,794 | 0.6% |
| Sienna Biopharmaceuticals(SNNAQ) | Common Stock | 82622H108 | $660 | 758,610 | 0.2% |